One FTSE 250 stock and one small-cap I’d consider buying with £2,000

Harvey Jones picks out two stocks that have been cheerfully defying the negative sentiment hitting their sectors.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Outsourcing has been a tough line of business lately, given the troubles afflicting the likes of Carillion, Interserve and Kier Group.

Serco, so good

International service company Serco Group (LSE: SRP) has done far better with its share price, up 37% in the last 12 months. It’s up another 4% today after its trading update for the first half of 2019 showed 20% growth in underlying trading profit and 6% for revenues.

Serco also reported a £3bn order intake, including the award of its largest-ever contract, with AASC. 2019 will be the third year in a row in which order intake exceeds revenues.

Top end

The share price also benefited as it reported FY19 revenue is expected to be around the top end of the previously-stated range of £2.9-3bn, while underlying trading profit guidance was maintained at around £105m.

Group CEO Rupert Soames said the £1.73bn FTSE 250 company enjoys the “strategic advantage of having a strong international footprint” with 4% organic growth driven by the Americas and Asia Pacific divisions. Its UK division posted an improved trading performance, boosted by the Carillion health facilities management acquisition completed in 2018.

Fighting back

There’s one “but” though. When Rupert Hargreaves looked at Serco stock in February, he concluded it was too expensive, trading at a vastly optimistic forward P/E of 19.9, and feared that even a slight disappointment in earnings could punish the share price. Now it trades at a whopping 24.8 times earnings, making it even more expensive.

Soames has done a great job of turning Serco around since his appointment five years ago, when the group was struggling. He’s returned the company to growth and driven through plenty of M&A activity, and deserves plaudits. The downside is that it looks a bit pricey, plus there’s no dividend.

Liontrust roars

Fund manager Liontrust Asset Management (LSE: LIO) has also had a good spell, its stock up 26% in the past six months. But it’s flat today despite impressive final results showing a 10% rise in adjusted profit before tax to £30.1m and record inflows of nearly £1.8bn.

Revenues also rose 10% to £85m while profit before tax rose a bumper 55% to £19m, helped by a £4m drop in costs to £11.1m. Record net inflows for the year to 31 March totalled £1.78m, up from just over £1bn last year, particularly impressive given recent market bumpiness. CEO John Ions said a 21% increase in assets under management emphasise another successful year for Liontrust.”

He pinned this success on building an impressive group of investment teams, along with a great distribution franchise and a strong and distinctive brand.” Lionstust has always been respected by the brokers I talk to (mind you, so was Neil Woodford). 

Watch it

The share price is a bit less toppy than Serco’s at 13.5 times earnings and investors get a 3% yield and a progressive management attitude as well, with the total dividend per share lifted 27%.

Edward Sheldon also rates this small-cap champion, whose market-cap is just £367m. He even suggests it could be a takeover target. Fund managers are highly exposed to stock market fortunes. Maybe one to stick on your watch list for the next dip?

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »